Table 8.
The in vitro pathogenic potential of targets 5(a–l).
| Compound No. |
Zone of Inhibition for Antimicrobials (mm) after 1 Day at 200 g/mL Concentration | |||||
|---|---|---|---|---|---|---|
| Bacterial and Its Resistance | Fungal and Its Resistance | |||||
| Gram-Positive | Gram-Negative | |||||
| Bacillus subtilis | Staphylococcus aureus | Escherichia coli | Proteus vulgaris | Aspergillus niger | A. flavus | |
| 5a | 35.21 | 39.19 | 30.05 | 34.21 | 32.31 | 36.22 |
| 5b | 30.31 | 33.36 | 24.42 | 27.29 | 25.15 | 29.32 |
| 5c | 19.14 | 21.19 | 14.08 | 15.21 | 13.29 | 17.09 |
| 5d | 10.21 | 11.31 | 06.29 | 08.05 | 07.32 | 09.20 |
| 5e | 16.05 | 18.07 | 10.01 | 14.16 | 10.41 | 12.16 |
| 5f | 40.12 | 42.14 | 38.05 | 39.22 | 36.19 | 40.14 |
| 5g | 07.18 | 09.23 | 04.11 | 05.31 | 06.02 | 08.21 |
| 5h | 22.41 | 28.12 | 16.15 | 19.42 | 18.30 | 24.05 |
| 5i | 05.32 | 06.10 | 02.16 | 04.01 | 04.38 | 05.11 |
| 5j | 24.02 | 29.05 | 20.06 | 21.33. | 22.22 | 26.11 |
| 5k | 38.15 | 41.03 | 35.11 | 37.16 | 35.03 | 39.05 |
| 5l | 34.05 | 36.30 | 25.21 | 29.07 | 30.42 | 33.17 |
| Ciprofloxacin | 41.22 | 44.30 | 36.21 | 40.22 | - | - |
| Ketoconazole | - | - | - | - | 38.45 | 41.24 |
| Control(DMSO) | - | - | - | - | - | - |